UniSa - IRIS Institutional Research Information System

PICILLO, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 16.933
NA - Nord America 9.422
EU - Europa 4.003
SA - Sud America 1.190
Continente sconosciuto - Info sul continente non disponibili 501
AF - Africa 135
OC - Oceania 70
Totale 32.254
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 12.232
US - Stati Uniti d'America 9.131
SG - Singapore 2.096
IT - Italia 1.736
CN - Cina 945
BR - Brasile 929
VN - Vietnam 724
RU - Federazione Russa 479
UA - Ucraina 344
DE - Germania 283
IE - Irlanda 233
FR - Francia 230
KR - Corea 195
TR - Turchia 178
SE - Svezia 160
CA - Canada 140
BD - Bangladesh 134
GB - Regno Unito 134
IN - India 109
AR - Argentina 94
FI - Finlandia 76
EE - Estonia 69
MX - Messico 68
JP - Giappone 59
NL - Olanda 59
IQ - Iraq 48
AU - Australia 43
CO - Colombia 43
PL - Polonia 42
ES - Italia 37
ZA - Sudafrica 37
EC - Ecuador 34
VE - Venezuela 33
PK - Pakistan 32
AT - Austria 25
NZ - Nuova Zelanda 25
ID - Indonesia 23
CZ - Repubblica Ceca 22
UZ - Uzbekistan 22
MA - Marocco 21
JM - Giamaica 18
KE - Kenya 18
PY - Paraguay 15
CL - Cile 13
MY - Malesia 13
SA - Arabia Saudita 13
CR - Costa Rica 12
BO - Bolivia 11
DZ - Algeria 11
PH - Filippine 11
UY - Uruguay 11
IL - Israele 10
NP - Nepal 10
OM - Oman 10
CH - Svizzera 9
GT - Guatemala 8
KZ - Kazakistan 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
EG - Egitto 7
ET - Etiopia 7
JO - Giordania 7
LB - Libano 7
NI - Nicaragua 7
PA - Panama 7
TN - Tunisia 7
BG - Bulgaria 6
PE - Perù 6
AL - Albania 5
BE - Belgio 5
HN - Honduras 5
MK - Macedonia 5
MN - Mongolia 5
BS - Bahamas 4
EU - Europa 4
HU - Ungheria 4
LK - Sri Lanka 4
PT - Portogallo 4
RS - Serbia 4
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GR - Grecia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
NO - Norvegia 3
PR - Porto Rico 3
AM - Armenia 2
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DM - Dominica 2
GA - Gabon 2
HR - Croazia 2
KH - Cambogia 2
Totale 31.711
Salva come PNG Salva come JPEG
Città #
Hong Kong 12.217
Ann Arbor 1.168
San Jose 1.060
Singapore 985
Milan 730
Ashburn 613
Princeton 613
Chandler 521
Dallas 507
Wilmington 472
Jacksonville 412
Council Bluffs 359
Houston 305
Beijing 245
Dublin 225
The Dalles 193
Lauterbourg 192
Ho Chi Minh City 183
Woodbridge 180
Rome 168
Los Angeles 156
Dong Ket 144
Izmir 143
Hanoi 142
New York 135
Santa Clara 132
Moscow 125
Naples 118
Andover 117
Nanjing 109
Boardman 82
São Paulo 78
Pellezzano 76
Figino 71
Tallinn 69
Buffalo 67
Salerno 67
Norwalk 64
Munich 55
Tokyo 52
Dearborn 46
Düsseldorf 46
Shenyang 44
Montreal 38
Fairfield 37
Frankfurt am Main 37
Redwood City 37
Turin 37
Orem 36
Changsha 35
West Jordan 35
Mestre 34
Rio de Janeiro 34
Phoenix 33
Haiphong 32
Nanchang 32
Da Nang 31
Warsaw 31
Nuremberg 30
Chicago 29
Memphis 29
Seoul 29
Columbus 28
San Francisco 28
Hebei 27
Pune 27
Amsterdam 26
Belo Horizonte 25
Curitiba 24
Seattle 24
Stockholm 24
Jiaxing 22
Mexico City 22
Atlanta 21
Brasília 21
Brooklyn 21
Bologna 20
Boston 20
Tashkent 20
Baghdad 19
San Diego 19
Toronto 19
Washington 19
Denver 18
Sydney 18
Chennai 17
Nairobi 17
Shanghai 16
Johannesburg 15
Lecce 15
London 15
Manchester 15
Porto Alegre 15
Tianjin 15
Can Tho 14
Charlotte 14
Auckland 13
Genoa 13
Guangzhou 13
Philadelphia 13
Totale 24.854
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.212
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 1.008
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 969
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 940
Sex Differences in Parkinson’s Disease: From Bench to Bedside 653
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 599
Gender differences in microRNA expression in levodopa-naive PD patients 581
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 550
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 536
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 534
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 519
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 472
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 466
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 462
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 417
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 399
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 393
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 362
Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada 345
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 343
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 334
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 332
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 331
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 317
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 280
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 249
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 227
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 218
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 216
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 202
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 194
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 186
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 182
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 179
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 172
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 171
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 167
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 160
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 160
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 158
Quitting smoking: An early non-motor feature of Parkinson's disease? 157
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 156
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 154
Increased bilirubin levels in de novo Parkinson's disease 152
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 150
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 150
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 149
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 145
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET 143
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 143
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 143
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 140
The relevance of gender in Parkinson's disease: a review 139
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 139
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 138
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 135
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 135
Gender and non motor fluctuations in Parkinson's disease: A prospective study 129
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 128
Early MRI findings in acquired hepatocerebral degeneration. 127
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 127
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 125
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 125
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 125
Impact of COVID-19 on neurological patients attending a botulinum toxin service 124
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 123
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 122
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 122
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 121
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 121
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 121
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 120
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 118
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 118
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 118
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 118
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 118
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 117
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 117
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 116
Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards 116
Uric acid relates to dopamine transporter availability in Parkinson's disease. 115
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 115
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 114
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 114
Non-motor correlates of smoking habits in de novo Parkinson's disease 114
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 113
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 112
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 112
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 111
Efficacy of Safinamide and Gender Differences During Routine Clinical Practice 111
Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy 109
Midbrain MRI assessments in progressive supranuclear palsy subtypes 108
Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms 107
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects 106
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 105
Brittle response to levodopa as a marker of Parkinson’s disease phenotype characterized by heavy motor and non-motor burden 104
The language profile of progressive supranuclear palsy 104
Progressive Supranuclear Palsy-Like Phenotype in a GBA E326K Mutation Carrier 103
Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonists 103
Totale 23.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.172
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022945 0 3 6 12 11 4 18 34 132 117 138 470
2022/20231.387 183 95 70 109 180 309 16 125 189 9 72 30
2023/2024947 52 116 44 65 34 113 42 83 61 78 79 180
2024/20252.692 84 26 46 164 106 233 341 248 465 315 344 320
2025/202620.902 3.579 5.250 4.530 721 1.114 484 1.538 336 556 1.053 292 1.449
2026/2027842 538 304 0 0 0 0 0 0 0 0 0 0
Totale 32.254